The mission of the Division of Addiction Science, Prevention and Treatment is “To reduce mortality and morbidity (death and suffering) from substance use disorders in Colorado and nationally through clinical treatment, research, and teaching.”
The Division of Addiction Science, Prevention and Treatment was established in 1999, in the Department of Psychiatry under the leadership of Thomas Crowley, M.D. Under the leadership of Paula Riggs M.D. who became Division Director in 2011, the Division has continued its commitment to excellence in teaching, research, and clinical practice has been facilitated by the close linkage between the Division’s research faculty and the Division’s clinical programs, collectively known as Addiction Research and Treatment Services (ARTS). Under the leadership of Kristen Dixion, MA, LPC, who became Executive Director of ARTS in 2015, ARTS began to further expand its addiction treatment programs and services in primary care medical settings. The Division, comprised of 17 faculty at or above the rank of Instructor, has maintained a strong national reputation receiving millions of dollars in NIH research support annually. Additionally, in the past five years, the Division has more than doubled the number of Division-affiliate research faculty members in order to expand collaborative research opportunities and capacity for multidisciplinary team research.
Addiction Research and Treatment Services (ARTS) is a collection of clinical program within the Division of Substance Dependence, Department of Psychiatry at the University of Colorado, School of Medicine. ARTS has provided residential and outpatient empirically supported substance abuse treatment services in Colorado for over 40 years, with an emphasis on psychosocial and pharmacological treatments for adolescents, women, men, families and those involved in the criminal justice system. ARTS is on the cutting edge of scientific research, medical education and clinical care for the purpose of reducing death and dying from addictive disorders.
ENCOMPASS is an integrated, evidence-based treatment for adolescents and young adults with co-occurring mental health and substance use disorders that can be feasibly implemented by providers and treatment programs who serve such youth. ENCOMPASS was developed by a research team, led by Dr. Paula Riggs, Professor of Psychiatry at the University of Colorado, School of Medicine, and is based on more than 15 years of clinical research. ENCOMPASS is affiliated with Synergy Adolescent Treatment Services and the University's Division of Addiction Science, Prevention and Treatment.
The Division of Addiction Science, Prevention and Treatment received its first research grant about 40 years ago from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health. Since then we have successfully and consistently received funds from various sources for a variety of research projects.
Some current foci of our research:
Adolescent Substance Abuse and ADHD
Genetics of adolescent drug dependence
Behavioral interventions to control the spread of HIV and hepatitis C among drug users
Efficacy of psychosocial and pharmacologic treatments
Clinical description and classification of substance use disorders
Behavioral processes of drug reinforcement
Functional MRI brain imaging of substance-dependent adolescents
Project Safe is a research program of the Division of Addiction Science, Prevention and Treatment, Department of Psychiatry, at the University of Colorado, School of Medicine. We strive to reduce the spread of HIV and HEP C through research based prevention education, drug treatment facilitation, social service referrals, and street outreach. We have been in existence since 1987, under the direction of Drs. Robert Booth, PhD, and Karen Corsi, ScD, MPH, with the majority of funding provided by the National Institute on Drug Abuse (NIDA).
For more information about current studies please call 1-800-429-9240.
Division of Substance Abuse
13001 E. 17th Place
Mail Stop F570
Aurora, CO 80045